Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)

Product Name: Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
CAS No.: 206055-78-9
Chemical Name: Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
Synonyms: LNA-C(N-Bz);LNA-C(N-Bz) phosphoramidite;DMTr-L-C(Bz)-3-CED-phosphoramidite;DMTr-LNA-C(Bz)-3-CED-phosphoramidite;5’-DMTr-LNA-C(N-Bz) phosphoramidite;5’-DMTr-LNA-C(N-Bz) CE Phosphoramidite;DMT-2’-0-4’-C-Locked-C(Bz)-Phosphoramidite;N4-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-O,4’-C-methylene-cytidine?3’-O-[(2-cyanoethyl)?(N,N-diisopropyl)]-phosphoramidite;N4-Benzoyl-5’-O-(4,4’-dimethoxy trityl)-2’-O,4’-C-methylene-cytidine 3’-O-[(2-cyanoethyl) (N,N-diisopropyl)]-phosphorramidite;Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
CBNumber: CB16160998
Molecular Formula: C47H52N5O9P
Formula Weight: 861.93
MOL File: 206055-78-9.mol

More

Less

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Property

pka: 8.57±0.20(Predicted)

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Chemical Properties,Usage,Production

Uses

DMTr-LNA-C(Bz)-3-CED-phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

References

[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Suppliers

China 14 United States 1 Global 15

Nanjing Baifuli Technology Co., Ltd.

Tel: 25-25-58740604 15951658055
Fax: +86-25-58356858
Email: sales@unisyn.cn
Country: China
ProdList: 591
Advantage: 58

Zhengzhou Granlen Sciences, ltd.

Tel: 0371-85513397 +86-18610099868
Email: info@granlen.com
Country: China
ProdList: 1890
Advantage: 58

NewCan Biotech Limited

Tel: +86-0571-86912261 +8613735419629
Email: sales@newcanbio.com
Country: China
ProdList: 9985
Advantage: 58

TargetMol Chemicals Inc.

Tel: 4008200310
Email: marketing@tsbiochem.com
Country: China
ProdList: 24961
Advantage: 58

Beijing Qinling Pharmaceutical Co., Ltd.

Tel: 010-61241352 18901327973
Email: 834537306@qq.com
Country: China
ProdList: 5860
Advantage: 58

Panaishen (Henan) Pharmaceutical Science and Technology Co. , Ltd.

Tel: 0371-65325800 13700860222
Email: haifeng.zhang@pannacean.com
Country: China
ProdList: 705
Advantage: 58

Shanghai Easy CDMO Co.,Ltd

Tel: 021-61734564 13854185395;
Email: info@easycdmo.com
Country: China
ProdList: 10024
Advantage: 58

Suzhou Meidi Senuo Pharmaceutical Technology Co., Ltd.

Tel: 13771642864
Fax: 1078336263
Email: snhuyu_2008@126.com
Country: China
ProdList: 1165
Advantage: 58

Jilin Chinese Academy of Sciences-yanshen Technology

Tel: 18143011203
Email: ET-market@chemextension.com
Country: China
ProdList: 32084
Advantage: 58

Pharmalego

Tel: 18321033991
Email: marketing@pharmalego.com
Country: China
ProdList: 3582
Advantage: 58

206055-78-9, Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)Related Search:

N4-Benzoyl-5‘-O-(4,4'-dimethoxytrityl)-5-methylcytidine Benzamide, N-[1-[2,5-anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-α-L-lyxofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]- N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-methylcytidine

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)

N4-Benzoyl-5’-O-(4,4’-dimethoxy trityl)-2’-O,4’-C-methylene-cytidine 3’-O-[(2-cyanoethyl) (N,N-diisopropyl)]-phosphorramidite

DMTr-LNA-C(Bz)-3-CED-phosphoramidite

N4-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-2’-O,4’-C-methylene-cytidine?3’-O-[(2-cyanoethyl)?(N,N-diisopropyl)]-phosphoramidite

DMTr-L-C(Bz)-3-CED-phosphoramidite

N-(1-[(1R,3R,4R,7S)-1-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-7-{[(bis(propan-2-yl)amino)(2-cyanoethoxy)phosphanyl]oxy}-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide

DMT-2’-0-4’-C-Locked-C(Bz)-Phosphoramidite

N-(1-[(1R,3R,4R,7S)-1-[(bis(4-methoxyphenyl)(phenyl)methoxy)methyl]-7-{[(bis(propan-2-yl)amino)(2-cyanoethoxy)phosphanyl]oxy}-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-2-oxo-1,2-dihydropyrimidin-4-yl)benzam

N-[1-[(1R,3R,4R,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphino]oxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-2-oxo-4-pyrimidinyl]benzamide

(1R,3R,4R,7S)-3-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-1-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-2,5-dioxabicyclo[2.2.1]heptan-7-yl (2-cyanoethyl) diisopropylphosphoramidite

5’-DMTr-LNA-C(N-Bz) CE Phosphoramidite

5’-DMTr-LNA-C(N-Bz) phosphoramidite

LNA-C(N-Bz)

LNA-C(N-Bz) phosphoramidite

206055-78-9

C47H52N5O9P